Recommendations on How to Manage Anticipated Communication Dilemmas Involving Medical Countermeasures in an Emergency

Public Health Reports
Monica Schoch-SpanaMatthew P Shearer

Abstract

National investments to facilitate prompt access to safe and effective medical countermeasures (MCMs) (ie, products used to diagnose, prevent, protect from, or treat conditions associated with chemical, biological, radiological, or nuclear threats, or emerging infectious diseases) have little merit if people are not willing to take a recommended MCM during an emergency or inadvertently misuse or miss out on a recommended MCM during an emergency. Informed by the Expert Working Group on MCM Emergency Communication, the Johns Hopkins Center for Health Security developed recommendations for achieving desired public health outcomes through improved MCM communication based on a review of model practices in risk communication, crisis communication, and public warnings; detailed analysis of recent health crises involving MCMs; and development of a scenario depicting future MCM communication dilemmas. The public's topics of concern, emotional requirements, capacity for processing information, and health needs will evolve as an emergency unfolds, from a pre-event period of routine conditions, to a crisis state, to a post-event period of reflection. Thus, MCM communication by public health authorities requires a phased approach that spans...Continue Reading

References

Apr 1, 1995·Risk Analysis : an Official Publication of the Society for Risk Analysis·B Fischhoff
Dec 25, 2003·Journal of Health Communication·Vincent T Covello
Mar 26, 2004·Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science·Elin GurskyTara O'Toole
Nov 13, 2004·Health Education & Behavior : the Official Publication of the Society for Public Health Education·Marieke KoolsGerjo Kok
Feb 12, 2005·Emerging Infectious Diseases·Edward A BelongiaRichard E Besser
Jun 28, 2005·Journal of Biomedical Informatics·Alla KeselmanVimla L Patel
Jan 16, 2007·Annual Review of Public Health·Deborah C Glik
Dec 25, 2007·American Journal of Community Psychology·Fran H NorrisRose L Pfefferbaum
Jan 2, 2009·Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science·Sandra Crouse QuinnSupriya Kumar
Sep 25, 2009·Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science·Sandra Crouse QuinnDonald Musa
Sep 10, 2010·Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science·Monica Schoch-SpanaAnn Norwood
Dec 8, 2010·Journal of Public Health Management and Practice : JPHMP·Alonzo PloughSinan Khan
May 14, 2011·American Journal of Public Health·Lori Uscher-PinesKatherine M Harris
Jun 22, 2011·Risk Analysis : an Official Publication of the Society for Risk Analysis·Michele M WoodLinda B Bourque
Aug 9, 2011·Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science·Gillian SteelFisherJohanna R Mailhot
Dec 18, 2012·Disaster Medicine and Public Health Preparedness·Jaime R JonesAndrew M Parker
Mar 20, 2013·Canadian Pharmacists Journal : CPJ = Revue Des Pharmaciens Du Canada : RPC·Monica Durigon, Tom Kosatsky
Apr 23, 2013·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Brooke CourtneyMatthew Penn
Oct 22, 2013·Transcultural Psychiatry·Rebecca Lester
Dec 20, 2014·Annals of Emergency Medicine·Richard C DartEdward P Krenzelok
Jan 30, 2015·Health Physics·Robert C WhitcombD Lynn Evans
Jan 6, 2016·Pediatrics·UNKNOWN DISASTER PREPAREDNESS ADVISORY COUNCIL
Apr 8, 2017·Health Security·Brooke Fisher LiuNatalie Boonchaisri

❮ Previous
Next ❯

Citations

Apr 30, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Monica Schoch-Spana
Apr 4, 2020·Public Health Reports·Tara Kirk SellMonica Schoch-Spana
Jul 25, 2020·Health Security·Emily K Brunson, Monica Schoch-Spana
Jul 8, 2021·Risk, Hazards & Crisis in Public Policy·Samantha PentaKimberly Gill

❮ Previous
Next ❯

Software Mentioned

Google Scholar

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of the South Carolina Medical Association
Robert T Ball
The New England Journal of Medicine
William J GordonAdam Landman
Médecine tropicale : revue du Corps de santé colonial
S CotA M Gillet
© 2022 Meta ULC. All rights reserved